Archives of Pediatric Infectious Diseases

Published by: Kowsar

The Seroprevalence of Varicella Zoster Virus in a Healthy Population from Tehran, Iran

Alireza Fahimzad 1 , Mahdi Nouri 1 , Farideh Shiva 1 , Ahmad Reza Shamshiri 2 , Zari Gholinejad 1 and Abdollah Karimi 1 , *
Authors Information
1 Pediatric Infections Research Center, Research Institute For Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Archives of Pediatric Infectious Diseases: January 2018, 6 (1); e59883
  • Published Online: January 10, 2018
  • Article Type: Research Article
  • Received: January 11, 2016
  • Revised: September 2, 2017
  • Accepted: December 25, 2017
  • DOI: 10.5812/pedinfect.59883

To Cite: Fahimzad A, Nouri M, Shiva F, Shamshiri A R, Gholinejad Z, et al. The Seroprevalence of Varicella Zoster Virus in a Healthy Population from Tehran, Iran, Arch Pediatr Infect Dis. 2018 ; 6(1):e59883. doi: 10.5812/pedinfect.59883.

Copyright © 2018, Archives of Pediatric Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361-81. [PubMed: 8809466].
  • 2. Berger R, Florent G, Just M. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect Immun. 1981;32(1):24-7. [PubMed: 6163722].
  • 3. Holmes CN. Predictive value of a history of varicella infection. Can Fam Physician. 2005;51:60-5. [PubMed: 15732223].
  • 4. Wu MF, Yang YW, Lin WY, Chang CY, Soon MS, Liu CE. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection. J Hosp Infect. 2012;80(2):162-7. doi: 10.1016/j.jhin.2011.11.011. [PubMed: 22188630].
  • 5. Socan M, Berginc N, Lajovic J. Varicella susceptibility and transmission dynamics in Slovenia. BMC Public Health. 2010;10:360. doi: 10.1186/1471-2458-10-360. [PubMed: 20573202].
  • 6. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994;343(8912):1548-51. [PubMed: 7802767].
  • 7. Sauerbrei A. Varicella-zoster virus infections in pregnancy. Intervirology. 1998;41(4-5):191-6. doi: 10.1159/000024935. [PubMed: 10213895].
  • 8. Bayani M, Siadati S, Esmaeilzadeh S, Salmani S, Asgari S. Seroprevalence of varicella zoster antibodies among pregnant women in Babol, northern Iran. Iran J Pathol. 2013;8:171-7.
  • 9. Fairley CK, Miller E. Varicella zoster virus epidemiology a changing scene?. J Infect Dis. 1996;174:314-9. [PubMed: 8896538].
  • 10. Nichols RA, Averbeck KT, Poulsen AG, al Bassam MM, Cabral F, Aaby P, et al. Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity. Epidemics. 2011;3(1):12-8. doi: 10.1016/j.epidem.2010.11.003. [PubMed: 21420656].
  • 11. Black S, Shinefield H, Ray P, Lewis E, Hansen J, Schwalbe J, et al. Postmarketing evaluation of the safety and effectiveness of varicella vaccine. Pediatr Infect Dis J. 1999;18(12):1041-6. [PubMed: 10608621].
  • 12. Gershon AA. Varicella vaccine: its past, present and future. Pediatr Infect Dis J. 1995;14(9):742-4. [PubMed: 8559621].
  • 13. Robert Koch Institut . Impfempfehlungen der standigen impfkommission (STIKO) am robert koch institut. Epidemiologisches Bull. 2000;2:9–20.
  • 14. Ziyaeyan M, Alborzi A, Jamildoust M, Moeini M, Pourabbas B. Seroepidemiology of Varicella zoster virus infection among 1-70 year individuals in Iran. Iran Red Crescent Med J. 2010;12:176-80.
  • 15. Akram DS, Qureshi H, Mahmud A, Khan AA, Kundi Z, Shafi S, et al. Seroepidemiology of varicella-zoster in Pakistan. Southeast Asian J Trop Med Public Health. 2000;31(4):646-9. [PubMed: 11414405].
  • 16. Savas S, Dallar Y, Arikan I, Onde U. [Varicella-zoster virus seroprevalence in children between 0-15 years old]. Mikrobiyol Bul. 2004;38(1-2):69-75. [PubMed: 15293904].
  • 17. Allami A, Mohammadi N. Varicella immunity in Iran: an age-stratified systematic review and meta-analysis. Iran J Microbiol. 2014;6(6):372-81. [PubMed: 25926953].
  • 18. Khoshnood B, Debruyne M, Lancon F, Emery C, Fagnani F, Durand I, et al. Seroprevalence of varicella in the French population. Pediatr Infect Dis J. 2006;25(1):41-4. [PubMed: 16395101].
  • 19. Lupi O, Semenovitch I, Pereira ACJ. Herpes, cl.nica, diagn.stico e tratamento. In: Lupi O, Silva AG, Pereira ACJ, editors. Rio de Janeiro, Brazil: Medsi; 2000. Epidemiologia dos herpesv.rus; p. 15-31.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments